Pfizer CEO "COVID-19 Vaccine, Cautiously Optimistic About Effectiveness Against Variants"
"Related Research to be Completed Within 10-14 Days"
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2020122408500483579_1608767403.jpg)
[Asia Economy Reporter Yu Je-hoon] Albert Bourla, CEO of Pfizer, cautiously expressed optimism that "(Pfizer's) vaccine will be effective against the variant" related to the novel coronavirus (COVID-19) variant discovered in the United Kingdom, CNN reported on the 24th (local time).
According to the report, CEO Bourla stated at an online briefing hosted by the Navajo Nation in the United States, "We already have data showing that the variant responds to the vaccine (similarly to the original virus)."
Regarding future research directions, CEO Bourla said, "We have started experiments to see if the variant is neutralized by the vaccine," adding, "We will complete the special study within 10 to 14 days."
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
CEO Bourla also addressed allergic reactions observed in some vaccine recipients, saying, "They are very rare and not common. They occur at a rate of about one in hundreds of thousands," emphasizing that everyone, including those with underlying conditions, should receive the vaccine.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
